Inflammatory markers and the risk of coronary heart disease in men and women.

@article{Pai2004InflammatoryMA,
  title={Inflammatory markers and the risk of coronary heart disease in men and women.},
  author={Jennifer Pai and Tobias Pischon and Jing Ma and JoAnn E. Manson and Susan E. Hankinson and Kaumudi J. Joshipura and Gary C Curhan and Nader Rifai and Carolyn C Cannuscio and Meir J. Stampfer and Eric B. Rimm},
  journal={The New England journal of medicine},
  year={2004},
  volume={351 25},
  pages={
          2599-610
        }
}
BACKGROUND Few studies have simultaneously investigated the role of soluble tumor necrosis factor alpha (TNF-alpha) receptors types 1 and 2 (sTNF-R1 and sTNF-R2), C-reactive protein, and interleukin-6 as predictors of cardiovascular events. The value of these inflammatory markers as independent predictors remains controversial. METHODS We examined plasma levels of sTNF-R1, sTNF-R2, interleukin-6, and C-reactive protein as markers of risk for coronary heart disease among women participating in… Expand

Paper Mentions

Observational Clinical Trial
To determine the relationships of hormonal, reproductive, dietary, and lifestyle factors, as well as biochemical and genetic factors, with the subsequent risk of coronary heart disease… Expand
ConditionsAngina Pectoris, Cardiovascular Diseases, Cerebrovascular Accident, (+7 more)
Observational Clinical Trial
To test the hypothesis that increased risk of coronary heart disease, stroke, peripheral vascular disease, and cancer is related to diets high in saturated fat, animal protein, and… Expand
ConditionsCardiovascular Diseases, Cerebrovascular Accident, Coronary Disease, (+3 more)
Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.
TLDR
A potential role for TNFR1 and TNFR2 in identifying women with a higher MI risk is possible after adjustments for established cardiovascular risk factors in women but not in men, according to a nested case control study in three large Swedish cohorts. Expand
C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study.
TLDR
CRP and TNFalpha were significant, independent predictors of CHD and CVD events and total mortality among men, providing further support to the important role of inflammation in the pathogenesis of CVD. Expand
A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease.
TLDR
Findings suggest there are rapid consequences of smoking cessation on inflammatory biomarkers in women at risk for CVD and additional, larger studies are required to confirm changes in "measurable milestones" that could serve as motivating factors to assist smokers to quit. Expand
Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
TLDR
In patients hospitalized with chest pain, there was no association of serum levels of hs-CRP, IL-6, or TNF-alpha with coronary atherosclerotic burden or MACEs at 6 months after adjustment for traditional CAD risk factors. Expand
C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression.
TLDR
Blood levels of CRP, IL-6 and TNFα-R2 were not associated with incident depression over a follow-up of 6-18 years, and no associations with depression or antidepressant use were observed in the prospective analysis. Expand
Plasma Cytokines, Metabolic Syndrome, and Atherosclerosis in Humans
TLDR
Plasma IL-6 and sol-TNFR2 levels were independently associated with CAC, suggesting a role in integrating innate immune and adipose signaling in promoting atherosclerosis and cardiovascular risk. Expand
Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.
TLDR
Results indicate that the adverse impact of inflammation may be largely through other mechanisms than promotion of atherogenesis (ie, destabilization of vulnerable plaques) and development of global measures of inflammation and simply counting the number of markers with high levels improve CVD risk stratification. Expand
C-Reactive Protein (CRP) Gene Polymorphisms, CRP Levels, and Risk of Incident Coronary Heart Disease in Two Nested Case-Control Studies
TLDR
Common variation in the CRP gene was significantly associated with plasma CRP levels; however, the association between common SNPs andCRP levels did not correspond to a predicted change in CHD risk. Expand
EN-RAGE: A Novel Inflammatory Marker for Incident Coronary Heart Disease
TLDR
The results highlight neutrophil-derived human s100a12 (extracellular newly identified receptor for advanced glycation end-products binding protein [EN-RAGE] as an inflammatory marker for future CHD in a general population, beyond traditional CHD risk factors and inflammatory markers. Expand
INFLAMMATORY MARKERS AS NOVEL PREDICTORS OF CARDIOVASCULAR DISEASE
TLDR
Results suggest a moderate positive association of MMP-9 with coronary heart disease (CHD) risk, while serum sCD40L may be moderately inversely related to CHD risk, and the need for further research into novel inflammatory markers of CVD risk. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 44 REFERENCES
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
TLDR
The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events. Expand
Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study
TLDR
A composite summary indicator of inflammation showed a strong association with incident cardiovascular events, with an especially high risk if all 3 inflammatory markers were in the highest tertile. Expand
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
TLDR
Findings suggest that some inflammatory processes, unrelated to the chronic infections studied here, are likely to be involved in coronary heart disease. Expand
The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.
TLDR
Measurement of CRP in elderly people has no additional value in coronary disease risk prediction when traditional cardiovascular risk factors are known. Expand
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
TLDR
These prospective findings indicate that CRP and IL-6 independently predict vascular events among apparently healthy postmenopausal women and that HRT increases CRP. Expand
Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).
TLDR
The findings suggest an important role for IL-6 and TNF-alpha in clinical as well as subclinical cardiovascular disease, and CRP had a weaker association with cardiovascular disease than the cytokines. Expand
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.
TLDR
A role for cytokine-mediated inflammation in the early stages of atherogenesis is supported in apparently healthy men, and elevated levels of IL-6 are associated with increased risk of future MI. Expand
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
TLDR
The long-term stability of C-reactive protein values was similar to that of both blood pressure and total serum cholesterol, and recommendations regarding its use in predicting the likelihood of coronary heart disease may need to be reviewed. Expand
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
TLDR
Elevated levels of CRP and IL-6 predict the development of type 2 DM, and data support a possible role for inflammation in diabetogenesis. Expand
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.
TLDR
Elevated levels of lipoprotein-associated phospholipase A2 appear to be a strong risk factor for coronary heart disease, a finding that has implications for atherogenesis and the assessment of risk. Expand
...
1
2
3
4
5
...